Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SPB 2514Session 2025

Health and Human Services

S 2514 pb

Underlined text would be added to current law. Struck-through text would be removed.

Florida Senate - 2025 (PROPOSED BILL) SPB 2514 FOR CONSIDERATION By the Committee on Appropriations 576-02654A-25 20252514pb 1 A bill to be entitled 2 An act relating to health and human services; amending 3 s. 381.4019, F.S.; authorizing certain dental and 4 dental hygiene students to apply for the Dental 5 Student Loan Repayment Program before obtaining active 6 employment; amending s. 381.915, F.S.; revising the 7 definitions of the terms “cancer center” and “Florida 8 based”; defining the term “Cancer Connect 9 Collaborative” or “collaborative”; making clarifying 10 changes; deleting an obsolete date; revising the 11 composition of the collaborative; deleting obsolete 12 provisions; requiring the collaborative to review all 13 submitted Cancer Innovation Fund grant applications 14 using certain parameters; requiring the collaborative 15 to give priority to certain applications; requiring 16 licensed or certified health care providers, 17 facilities, or entities to meet certain criteria to be 18 eligible for specified grant funding; specifying such 19 criteria; requiring the Department of Health to 20 appoint peer review panels for a specified purpose; 21 requiring that priority scores be forwarded to the 22 collaborative and be considered in determining which 23 proposals the collaborative recommends for certain 24 grant funding; requiring the collaborative and peer 25 review panels to establish and follow certain 26 guidelines and adhere to a certain policy; prohibiting 27 a member of the collaborative or a panel from 28 participating in certain discussions or decisions 29 under certain circumstances; requiring, beginning on a 30 specified date and annually thereafter, the 31 collaborative to prepare and submit a specified report 32 to the Governor and the Legislature; requiring that 33 the report include certain information; revising the 34 requirements for a specified report by the department; 35 requiring, beginning on a specified date, that certain 36 allocation agreements include certain information; 37 providing legislative findings; creating the Cancer 38 Connect Collaborative Research Incubator within the 39 department, and overseen by the collaborative, to 40 provide funding for a specified purpose over a 41 specified timeframe; specifying the incubator’s 42 targeted area of cancer research for the first 43 specified timeframe; providing that grants issued 44 through the incubator are contingent upon the 45 appropriation of funds and must be awarded through a 46 specified process; requiring that priority be given to 47 certain applicants; authorizing the prioritization of 48 certain grant proposals; providing that applications 49 for incubator funding may be submitted by specified 50 hospitals; requiring that all qualified applicants 51 have equal access and opportunity to compete for 52 research funding; requiring that incubator grants be 53 recommended by the collaborative and awarded by the 54 department in a certain manner; requiring the 55 department to appoint peer review panels for a 56 specified purpose; requiring that priority scores be 57 forwarded to the collaborative and be considered in 58 determining which proposals the collaborative 59 recommends for funding; requiring the collaborative 60 and peer review panels to establish and follow certain 61 guidelines and adhere to a certain policy; prohibiting 62 a member of the collaborative or a panel from 63 participating in certain discussions or decisions; 64 requiring recipients of incubator grant funds to enter 65 into an allocation agreement with the department; 66 specifying requirements for such allocation 67 agreements; requiring, beginning on a specified date 68 and annually until a specified date, the collaborative 69 to prepare and submit a specified report to the 70 Governor and the Legislature; requiring the 71 collaborative to make a certain recommendation under 72 certain circumstances; requiring that a specified 73 report include certain information; amending s. 74 381.922, F.S.; establishing the Bascom Palmer Eye 75 Institute VisionGen Initiative within the William G. 76 “Bill” Bankhead, Jr., and David Coley Cancer Research 77 Program; providing the purpose of the initiative; 78 providing that funding for the initiative is subject 79 to annual appropriation; amending s. 381.986, F.S.; 80 requiring the Department of Health to revoke the 81 medical marijuana use registry registration of 82 qualified patients and caregivers who enter certain 83 pleas or are found guilty of certain offenses; 84 amending s. 394.495, F.S.; authorizing the Department 85 of Children and Families to contract with a specified 86 nonprofit organization to provide certain grief 87 support services to help certain children and youth; 88 authorizing the provision of certain training and 89 outreach under the contract; reviving, reenacting, and 90 amending s. 400.0225, F.S., relating to consumer 91 satisfaction surveys; requiring the Agency for Health 92 Care Administration to develop user-friendly consumer 93 satisfaction surveys for nursing home facilities; 94 specifying requirements for the surveys; authorizing 95 family members, guardians, and other resident 96 designees to assist the resident in completing the 97 survey; prohibiting employees and volunteers of the 98 facility or of a corporation or business entity with 99 an ownership interest in the facility from attempting 100 to influence a resident’s responses to the survey; 101 requiring the agency to specify certain protocols for 102 administration of the survey; requiring the agency to 103 publish on its website aggregated survey data in a 104 manner that allows for comparison between nursing home 105 facilities; amending s. 400.141, F.S.; requiring 106 medical directors of nursing home facilities to 107 obtain, or to be in the process of obtaining, certain 108 qualifications by a specified date; requiring the 109 agency to include such medical director’s name on each 110 nursing home facility’s online provider profile; 111 requiring nursing home facilities to conduct biennial 112 patient safety culture surveys; specifying 113 requirements for administration of such surveys; 114 requiring nursing home facilities to submit the 115 results of such surveys biennially to the agency in a 116 format specified by agency rule; authorizing nursing 117 home facilities to develop an internal action plan 118 between surveys to identify measures for improvement 119 of the survey and submit such plan to the agency; 120 amending s. 400.191, F.S.; requiring the agency to 121 include the results from specified consumer 122 satisfaction surveys as part of the Nursing Home Guide 123 on its website; amending s. 408.051, F.S.; requiring 124 nursing home facilities that maintain certain 125 electronic health records to make available certain 126 data to the agency’s Florida Health Information 127 Exchange program for a specified purpose; authorizing 128 the agency to adopt rules; amending s. 408.061, F.S.; 129 exempting nursing homes operated by state agencies 130 from certain financial reporting requirements; 131 requiring the agency to impose administrative fines 132 against nursing homes and home offices of nursing 133 homes for failing to comply with certain reporting 134 requirements; defining the term “violation”; providing 135 construction; requiring the agency to adopt rules; 136 providing requirements for such rules; amending s. 137 408.08, F.S.; prohibiting nursing homes subject to 138 certain administrative fines from being fined under a 139 specified provision for the same violation; amending 140 s. 409.908, F.S.; requiring the agency to revise its 141 methodology for calculating Quality Incentive Program 142 payments; providing requirements for such revision; 143 requiring the agency to submit an annual report to the 144 Governor and the Legislature on payments made under 145 the Quality Incentive Program; specifying requirements 146 for the report; amending s. 409.91256, F.S.; revising 147 the purpose of the Training, Education, and Clinicals 148 in Health Funding Program; revising the definition of 149 the term “qualified facility”; specifying an allowed 150 reimbursement rate to qualified facilities under the 151 program for nursing students; requiring the agency to 152 contract with a third-party vendor to conduct a 153 comprehensive study of nursing home quality incentive 154 programs in other states; providing minimum 155 requirements for the report; requiring the agency to 156 submit a final report on the study to the Governor and 157 the Legislature by a specified date; providing an 158 effective date. 159 160 Be It Enacted by the Legislature of the State of Florida: 161 162 Section 1. Present subsections (5) through (10) of section 163 381.4019, Florida Statutes, are redesignated as subsections (6) 164 through (11), respectively, and a new subsection (5) is added to 165 that section, to read: 166 381.4019 Dental Student Loan Repayment Program.—The Dental 167 Student Loan Repayment Program is established to support the 168 state Medicaid program and promote access to dental care by 169 supporting qualified dentists and dental hygienists who treat 170 medically underserved populations in dental health professional 171 shortage areas or medically underserved areas. 172 (5) A dental student or dental hygiene student who 173 demonstrates an offer of employment in a public health program 174 or private practice as specified in paragraph (2)(a) may apply 175 for the loan program before obtaining active employment but may 176 not be awarded funds from the loan program until he or she meets 177 the requirements of subsection (2). 178 Section 2. Present paragraphs (c), (d), and (e) of 179 subsection (3) and present subsections (12) and (13) of section 180 381.915, Florida Statutes, are redesignated as paragraphs (d), 181 (e), and (f) of subsection (3) and subsections (13) and (14), 182 respectively, a new paragraph (c) is added to subsection (3), 183 paragraph (d) is added to subsection (10), a new subsection (12) 184 is added to that section, and paragraph (b) and present 185 paragraph (c) of subsection (3), paragraphs (a), (b), (e), (f), 186 and (h) of subsection (8), and subsections (9) and (11) of that 187 section are amended, to read: 188 381.915 Casey DeSantis Cancer Research Program.— 189 (3) On or before September 15 of each year, the department 190 shall calculate an allocation fraction to be used for 191 distributing funds to participating cancer centers. On or before 192 the final business day of each quarter of the state fiscal year, 193 the department shall distribute to each participating cancer 194 center one-fourth of that cancer center’s annual allocation 195 calculated under subsection (6). The allocation fraction for 196 each participating cancer center is based on the cancer center’s 197 tier-designated weight under subsection (4) multiplied by each 198 of the following allocation factors based on activities in this 199 state: number of reportable cases, peer-review costs, and 200 biomedical education and training. As used in this section, the 201 term: 202 (b) “Cancer center” means a comprehensive center with at 203 least one geographic site in the state, a freestanding center 204 located in the state, a center situated within an academic 205 institution, or a Florida-based formal research-based consortium 206 under centralized leadership that has achieved NCI designation 207 or is prepared to achieve NCI designation by June 30, 2024. 208 (c) “Cancer Connect Collaborative” or “collaborative” means 209 the council created under subsection (8). 210 (d)(c) “Florida-based” means that a cancer center’s actual 211 or sought designated status is or would be recognized by the NCI 212 as primarily located in Florida and not in another state, or 213 that a health care provider or facility is physically located in 214 Florida and provides services in Florida. 215 (8) The Cancer Connect Collaborative, a council as defined 216 in s. 20.03, is created within the department to advise the 217 department and the Legislature on developing a holistic approach 218 to the state’s efforts to fund cancer research, cancer 219 facilities, and treatments for cancer patients. The 220 collaborative may make recommendations on proposed legislation, 221 proposed rules, best practices, data collection and reporting, 222 issuance of grant funds, and other proposals for state policy 223 relating to cancer research or treatment. 224 (a) The Surgeon General shall serve as an ex officio, 225 nonvoting member of the collaborative and shall serve as the 226 chair. 227 (b) The collaborative shall be composed of the following 228 voting members, to be appointed by September 1, 2024: 229 1. Two members appointed by the Governor, three members one 230 member appointed by the President of the Senate, and three 231 members one member appointed by the Speaker of the House of 232 Representatives, based on the criteria of this subparagraph. The 233 appointing officers shall make their appointments prioritizing 234 members who have the following experience or expertise: 235 a. The practice of a health care profession specializing in 236 oncology clinical care or research; 237 b. The development of preventive and therapeutic treatments 238 to control cancer; 239 c. The development of innovative research into the causes 240 of cancer, the development of effective treatments for persons 241 with cancer, or cures for cancer; or 242 d. Management-level experience with a cancer center 243 licensed under chapter 395. 244 2. One member who is a resident of this state who can 245 represent the interests of cancer patients in this state, 246 appointed by the Governor. 247 (e) Members of the collaborative whose terms have expired 248 may continue to serve until replaced or reappointed, but for no 249 more than 6 months after the expiration of their terms. 250 (f) Members of the collaborative shall serve without 251 compensation but are entitled to reimbursement for per diem and 252 travel expenses pursuant to s. 112.061. 253 (h) The collaborative shall develop a long-range 254 comprehensive plan for the Casey DeSantis Cancer Research 255 Program. In the development of the plan, the collaborative must 256 solicit input from cancer centers, research institutions, 257 biomedical education institutions, hospitals, and medical 258 providers. The collaborative shall submit the plan to the 259 Governor, the President of the Senate, and the Speaker of the 260 House of Representatives no later than December 1, 2024. The 261 plan must include, but need not be limited to, all of the 262 following components: 263 1. Expansion of grant fund opportunities to include a 264 broader pool of Florida-based cancer centers, research 265 institutions, biomedical education institutions, hospitals, and 266 medical providers to receive funding through the Cancer 267 Innovation Fund. 268 2. An evaluation to determine metrics that focus on patient 269 outcomes, quality of care, and efficacy of treatment. 270 3. A compilation of best practices relating to cancer 271 research or treatment. 272 (9)(a) The collaborative shall advise the department on the 273 awarding of grants issued through the Cancer Innovation Fund. 274 During any fiscal year for which funds are appropriated to the 275 fund, the collaborative shall review all submitted grant 276 applications using the parameters provided in paragraph (c) and 277 make recommendations to the department for awarding grants to 278 support innovative cancer research and treatment models, 279 including emerging research and treatment trends and promising 280 treatments that may serve as catalysts for further research and 281 treatments. The department shall make the final grant allocation 282 awards. The collaborative shall give priority to applications 283 seeking to expand the reach of cancer screening efforts and 284 innovative cancer treatment models into underserved areas of 285 this state. 286 (b) To be eligible for grant funding under this subsection, 287 a licensed or certified health care provider, facility, or 288 entity must meet at least one of the following criteria: 289 1. Operates as a licensed hospital that has a minimum of 30 290 percent of its current cancer patients residing in rural or 291 underserved areas. 292 2. Operates as a licensed health care clinic or facility 293 that employs or contracts with at least one physician licensed 294 under chapter 458 or chapter 459 who is board certified in 295 oncology and that administers chemotherapy treatments for 296 cancer. 297 3. Operates as a licensed facility that employs or 298 contracts with at least one physician licensed under chapter 458 299 or chapter 459 who is board certified in oncology and that 300 administers radiation therapy treatments for cancer. 301 4. Operates as a licensed health care clinic or facility 302 that provides cancer screening services at no cost or a minimal 303 cost to patients. 304 5. Operates as a rural hospital as defined in s. 305 395.602(2)(b). 306 6. Operates as a critical access hospital as defined in s. 307 408.07(14). 308 7. Operates as a specialty hospital as defined in s. 309 395.002(28)(a) which provides cancer treatment for patients from 310 birth to 18 years of age. 311 8. Engages in biomedical research intended to develop 312 therapies, medical pharmaceuticals, treatment protocols, or 313 medical procedures intended to cure cancer or improve the 314 quality of life of cancer patients. 315 9. Educates or trains students, postdoctoral fellows, or 316 licensed or certified health care practitioners in the 317 screening, diagnosis, or treatment of cancer. 318 (c) To ensure that all proposals for grant funding issued 319 through the Cancer Innovation Fund are appropriate and are 320 evaluated fairly on the basis of scientific merit, the 321 department shall appoint peer review panels of independent, 322 scientifically qualified individuals to review the scientific 323 merit of each proposal and establish its priority score. The 324 priority scores must be forwarded to the collaborative and must 325 be considered in determining which proposals the collaborative 326 recommends for grant funding through the Cancer Innovation Fund. 327 (d) The collaborative and the peer review panels shall 328 establish and follow rigorous guidelines for ethical conduct and 329 adhere to a strict policy with regard to conflicts of interest 330 regarding the assessment of Cancer Innovation Fund grant 331 applications. A member of the collaborative or a panel may not 332 participate in any discussion or decision of the collaborative 333 or a panel with respect to a research proposal by any firm, 334 entity, or agency with which the member is associated as a 335 member of the governing body or as an employee or with which the 336 member has entered into a contractual arrangement. 337 (e) Beginning December 1, 2025, and annually thereafter, 338 the collaborative shall prepare and submit a report to the 339 Governor, the President of the Senate, and the Speaker of the 340 House of Representatives which identifies and evaluates the 341 performance and the impact of grants issued through the Cancer 342 Innovation Fund on cancer treatment, research, screening, 343 diagnosis, prevention, practitioner training, workforce 344 education, and cancer patient survivorship. The report must 345 include all of the following: 346 1. Amounts of grant funds awarded to each recipient. 347 2. Descriptions of each recipient’s research or project 348 which include, but need not be limited to, the following: 349 a. Goals or projected outcomes. 350 b. Population to be served. 351 c. Research methods or project implementation plan. 352 3. An assessment of grant recipients which evaluates their 353 progress toward achieving objectives specified in each 354 recipient’s grant application. 355 4. Recommendations for best practices that may be 356 implemented by health care providers in this state who diagnose, 357 treat, and screen for cancer, based on the outcomes of projects 358 funded through the Cancer Innovation Fund. 359 (10) Beginning July 1, 2025, and each year thereafter, the 360 department, in conjunction with participating cancer centers, 361 shall submit a report to the Cancer Control and Research 362 Advisory Council and the collaborative on specific metrics 363 relating to cancer mortality and external funding for cancer 364 related research in this state. If a cancer center does not 365 endorse this report or produce an equivalent independent report, 366 the cancer center is ineligible to receive program funding for 1 367 year. The department must submit this annual report, and any 368 equivalent independent reports, to the Governor, the President 369 of the Senate, and the Speaker of the House of Representatives 370 no later than September 15 of each year the report or reports 371 are submitted by the department. The report must include: 372 (d) A description of the numbers and types of cancer cases 373 treated annually at each participating cancer center, including 374 reportable and nonreportable cases. 375 (11) Beginning July 1, 2025 2024, each allocation agreement 376 issued by the department relating to cancer center payments 377 under paragraph (2)(a) subsection (2) must include all of the 378 following: 379 (a) A line-item budget narrative documenting the annual 380 allocation of funds to a cancer center. 381 (b) A cap on the annual award of 15 percent for 382 administrative expenses. 383 (c) A requirement for the cancer center to submit quarterly 384 reports of all expenditures made by the cancer center with funds 385 received through the Casey DeSantis Cancer Research Program. 386 (d) A provision to allow the department and other state 387 auditing bodies to audit all financial records, supporting 388 documents, statistical records, and any other documents 389 pertinent to the allocation agreement. 390 (e) A provision requiring the annual reporting of outcome 391 data and protocols used in achieving those outcomes. 392 (12)(a) The Legislature finds that targeted areas of cancer 393 research require increased resources and that Florida should 394 become a leader in promoting research opportunities for these 395 targeted areas. Floridians should not have to leave the state to 396 receive the most advanced cancer care and treatment. To meet 397 this need, the Cancer Connect Collaborative Research Incubator, 398 or “incubator” as used in this subsection, is created within the 399 department, to be overseen by the collaborative, to provide 400 funding for a targeted area of cancer research over a 5-year 401 period. For the 5-year period beginning July 1, 2025, the 402 incubator’s targeted area of cancer research is pediatric 403 cancer. 404 (b) Contingent upon the appropriation of funds by the 405 Legislature, grants issued through the incubator must be awarded 406 through a peer-reviewed, competitive process. Priority must be 407 given to applicants that focus on enhancing both research and 408 treatment by increasing participation in clinical trials related 409 to the targeted area of cancer research, including all of the 410 following: 411 1. Identifying strategies to increase enrollment in cancer 412 clinical trials. 413 2. Supporting public and private professional education 414 programs to raise awareness and knowledge about cancer clinical 415 trials. 416 3. Providing tools for cancer patients and community-based 417 oncologists to help identify available cancer clinical trials in 418 this state. 419 4. Creating opportunities for the state’s academic cancer 420 centers to collaborate with community-based oncologists in 421 cancer clinical trial networks. 422 (c) Priority may be given to grant proposals that foster 423 collaborations among institutions, researchers, and community 424 practitioners to support the advancement of cures through basic 425 or applied research, including clinical trials involving cancer 426 patients and related networks. 427 (d) Applications for incubator funding may be submitted by 428 any Florida-based specialty hospital as defined in s. 429 395.002(28)(a) which provides cancer treatment for patients from 430 birth to 18 years of age. All qualified applicants must have 431 equal access and opportunity to compete for research funding. 432 Incubator grants must be recommended by the collaborative and 433 awarded by the department on the basis of scientific merit, as 434 determined by a competitively open and peer-reviewed process to 435 ensure objectivity, consistency, and high quality. 436 (e) To ensure that all proposals for research funding are 437 appropriate and are evaluated fairly on the basis of scientific 438 merit, the department shall appoint peer review panels of 439 independent, scientifically qualified individuals to review the 440 scientific merit of each proposal and establish its priority 441 score. The priority scores must be forwarded to the 442 collaborative and must be considered in determining which 443 proposals the collaborative recommends for funding. 444 (f) The collaborative and the peer review panels shall 445 establish and follow rigorous guidelines for ethical conduct and 446 adhere to a strict policy with regard to conflicts of interest 447 regarding the assessment of incubator grant applications. A 448 member of the collaborative or a panel may not participate in 449 any discussion or decision of the collaborative or a panel 450 regarding a research proposal from any firm, entity, or agency 451 with which the member is associated as a governing body member, 452 as an employee, or through a contractual arrangement. 453 (g) Each recipient of incubator grant funds must enter into 454 an allocation agreement with the department. Each such 455 allocation agreement must include all of the following: 456 1. A line-item budget narrative documenting the annual 457 allocation of funds to a recipient. 458 2. A cap on the annual award of 15 percent for 459 administrative expenses. 460 3. A requirement for the recipient to submit quarterly 461 reports of all expenditures made by the recipient with funds 462 received through the incubator. 463 4. A provision to allow the department and other state 464 auditing bodies to audit all financial records, supporting 465 documents, statistical records, and any other documents 466 pertinent to the allocation agreement. 467 5. A provision requiring the annual reporting of outcome 468 data and protocols used in achieving those outcomes. 469 (h) Beginning December 1, 2026, and annually through 470 December 1, 2030, the collaborative shall prepare and submit a 471 report to the Governor, the President of the Senate, and the 472 Speaker of the House of Representatives which evaluates research 473 conducted through the incubator and provides details on outcomes 474 and findings available through the end of the fiscal year 475 immediately preceding each report. If the collaborative 476 recommends that the incubator be extended beyond its 5-year 477 lifespan, the collaborative shall make such recommendation in 478 the report due December 1, 2029, and shall include a 479 recommendation for the next targeted area of cancer research. 480 The report due on December 1, 2030, must include all of the 481 following: 482 1. Details of all results of the research conducted with 483 incubator funding which has been completed or the status of 484 research in progress. 485 2. An evaluation of all research conducted with incubator 486 funding during the 5 fiscal years preceding the report. 487 Section 3. Paragraph (d) is added to subsection (2) of 488 section 381.922, Florida Statutes, to read: 489 381.922 William G. “Bill” Bankhead, Jr., and David Coley 490 Cancer Research Program.— 491 (2) The program shall provide grants for cancer research to 492 further the search for cures for cancer. 493 (d) There is established within the program the Bascom 494 Palmer Eye Institute VisionGen Initiative. The purpose of the 495 initiative is to advance genetic and epigenetic research on 496 inherited eye diseases and ocular oncology by awarding grants 497 through the peer-reviewed, competitive process established under 498 subsection (3). Funding for the initiative is subject to the 499 annual appropriation of funds by the Legislature. 500 Section 4. Paragraphs (d) and (e) of subsection (5) of 501 section 381.986, Florida Statutes, are amended to read: 502 381.986 Medical use of marijuana.— 503 (5) MEDICAL MARIJUANA USE REGISTRY.— 504 (d) The department shall immediately suspend the 505 registration of a qualified patient charged with a violation of 506 chapter 893 until final disposition of the any alleged offense. 507 Based upon such final disposition Thereafter, the department may 508 extend the suspension, revoke the registration, or reinstate the 509 registration. However, the department must revoke the 510 registration of the qualified patient upon such final 511 disposition if the qualified patient entered a plea of guilty or 512 nolo contendere or was found guilty of the offense. 513 (e) The department shall immediately suspend the 514 registration of a any caregiver charged with a violation of 515 chapter 893 until final disposition of the any alleged offense. 516 The department must revoke the registration of the caregiver 517 upon such final disposition if the caregiver entered a plea of 518 guilty or nolo contendere or was found guilty of the offense. 519 Additionally, the department must shall revoke a caregiver 520 registration if the caregiver does not meet the requirements of 521 subparagraph (6)(b)6. 522 Section 5. Subsection (8) is added to section 394.495, 523 Florida Statutes, to read: 524 394.495 Child and adolescent mental health system of care; 525 programs and services.— 526 (8) As authorized by and consistent with funding 527 appropriated in the General Appropriations Act, the department 528 may contract with Valerie’s House, Inc., a nonprofit 529 organization exempt from taxation pursuant to s. 501(c)(3) of 530 the Internal Revenue Code, to provide grief support services to 531 help children and youth ages 4 to 19 who have experienced the 532 death of a parent or sibling. The services provided must be at 533 no cost to the bereaved child or his or her caregiver and may 534 include, but are not limited to, grief support groups, 535 mentoring, individual grief counseling, financial crisis 536 support, and in-school support services. Valerie’s House, Inc., 537 may also provide grief awareness training and outreach to local 538 schools and medical facilities under the contract. 539 Section 6. Notwithstanding the repeal of section 400.0225, 540 Florida Statutes, in section 14 of chapter 2001-377, Laws of 541 Florida, that section is revived, reenacted, and amended to 542 read: 543 400.0225 Consumer satisfaction surveys.— 544 (1) The agency shall develop user-friendly consumer 545 satisfaction surveys to capture resident and family member 546 satisfaction with care provided by nursing home facilities. The 547 consumer satisfaction surveys must be based on a core set of 548 consumer satisfaction questions to allow for consistent 549 measurement and must be administered annually to a random sample 550 of long-stay and short-stay residents of each facility and their 551 family members. The survey tool must be based on an agency 552 validated survey instrument whose measures have received an 553 endorsement by the National Quality Forum. 554 (2) Family members, guardians, or other resident designees 555 may assist a resident in completing the consumer satisfaction 556 survey. 557 (3) Employees and volunteers of the nursing home facility 558 or of a corporation or business entity with an ownership 559 interest in the nursing home facility are prohibited from 560 attempting to influence a resident’s responses to the consumer 561 satisfaction survey. 562 (4) The agency shall specify the protocols for conducting 563 the consumer satisfaction surveys, ensuring survey validity, 564 reporting survey results, and protecting the identity of 565 individual respondents. The agency shall make aggregated survey 566 data available to consumers on the agency’s website pursuant to 567 s. 400.191(2)(a)15. in a manner that allows for comparison 568 between nursing home facilities, or its contractor, in 569 consultation with the nursing home industry and consumer 570 representatives, shall develop an easy-to-use consumer 571 satisfaction survey, shall ensure that every nursing facility 572 licensed pursuant to this part participates in assessing 573 consumer satisfaction, and shall establish procedures to ensure 574 that, at least annually, a representative sample of residents of 575 each facility is selected to participate in the survey. The 576 sample shall be of sufficient size to allow comparisons between 577 and among facilities. Family members, guardians, or other 578 resident designees may assist the resident in completing the 579 survey. Employees and volunteers of the nursing facility or of a 580 corporation or business entity with an ownership interest in the 581 facility are prohibited from assisting a resident with or 582 attempting to influence a resident’s responses to the consumer 583 satisfaction survey. The agency, or its contractor, shall survey 584 family members, guardians, or other resident designees. The 585 agency, or its contractor, shall specify the protocol for 586 conducting and reporting the consumer satisfaction surveys. 587 Reports of consumer satisfaction surveys shall protect the 588 identity of individual respondents. The agency shall contract 589 for consumer satisfaction surveys and report the results of 590 those surveys in the consumer information materials prepared and 591 distributed by the agency. 592 (5) The agency may adopt rules as necessary to implement 593 administer this section. 594 Section 7. Paragraph (b) of subsection (1) of section 595 400.141, Florida Statutes, is amended, and paragraph (x) is 596 added to that subsection, to read: 597 400.141 Administration and management of nursing home 598 facilities.— 599 (1) Every licensed facility shall comply with all 600 applicable standards and rules of the agency and shall: 601 (b) Appoint a medical director licensed pursuant to chapter 602 458 or chapter 459. By January 1, 2026, the medical director of 603 each nursing home facility must obtain designation as a 604 certified medical director by the American Medical Directors 605 Association, hold a similar credential bestowed by an 606 organization recognized by the agency, or be in the process of 607 seeking such designation or credentialing, according to 608 parameters adopted by agency rule. The agency shall include the 609 name of each nursing home facility’s medical director on the 610 facility’s provider profile published by the agency on its 611 website. The agency may establish by rule more specific criteria 612 for the appointment of a medical director. 613 (x) Conduct, at least biennially, a patient safety culture 614 survey using the applicable Survey on Patient Safety Culture 615 developed by the federal Agency for Healthcare Research and 616 Quality. Each facility shall conduct the survey anonymously to 617 encourage completion of the survey by staff working in or 618 employed by the facility. A facility may contract with a third 619 party to administer the survey. Each facility shall biennially 620 submit the survey data to the agency in a format specified by 621 agency rule, which must include the survey participation rate. 622 Each facility may develop an internal action plan between 623 conducting surveys to identify measures to improve the survey 624 and submit such plan to the agency. 625 Section 8. Paragraph (a) of subsection (2) of section 626 400.191, Florida Statutes, is amended to read: 627 400.191 Availability, distribution, and posting of reports 628 and records.— 629 (2) The agency shall publish the Nursing Home Guide 630 quarterly in electronic form to assist consumers and their 631 families in comparing and evaluating nursing home facilities. 632 (a) The agency shall provide an Internet site which must 633 shall include at least the following information either directly 634 or indirectly through a link to another established site or 635 sites of the agency’s choosing: 636 1. A section entitled “Have you considered programs that 637 provide alternatives to nursing home care?” which must shall be 638 the first section of the Nursing Home Guide and must which shall 639 prominently display information about available alternatives to 640 nursing homes and how to obtain additional information regarding 641 these alternatives. The Nursing Home Guide must shall explain 642 that this state offers alternative programs that allow permit 643 qualified elderly persons to stay in their homes instead of 644 being placed in nursing homes and must shall encourage 645 interested persons to call the Comprehensive Assessment Review 646 and Evaluation for Long-Term Care Services (CARES) Program to 647 inquire as to whether if they qualify. The Nursing Home Guide 648 must shall list available home and community-based programs and 649 must which shall clearly state the services that are provided, 650 including and indicate whether nursing home services are covered 651 under those programs when necessary included if needed. 652 2. A list by name and address of all nursing home 653 facilities in this state, including any prior name by which a 654 facility was known during the previous 24-month period. 655 3. Whether such nursing home facilities are proprietary or 656 nonproprietary. 657 4. The current owner of the facility’s license and the year 658 that that entity became the owner of the license. 659 5. The name of the owner or owners of each facility and 660 whether the facility is affiliated with a company or other 661 organization owning or managing more than one nursing facility 662 in this state. 663 6. The total number of beds in each facility and the most 664 recently available occupancy levels. 665 7. The number of private and semiprivate rooms in each 666 facility. 667 8. The religious affiliation, if any, of each facility. 668 9. The languages spoken by the administrator and staff of 669 each facility. 670 10. Whether or not each facility accepts Medicare or 671 Medicaid recipients or insurance, health maintenance 672 organization, United States Department of Veterans Affairs, 673 CHAMPUS program, or workers’ compensation coverage. 674 11. Recreational and other programs available at each 675 facility. 676 12. Special care units or programs offered at each 677 facility. 678 13. Whether the facility is a part of a retirement 679 community that offers other services pursuant to part III of 680 this chapter or part I or part III of chapter 429. 681 14. Survey and deficiency information, including all 682 federal and state recertification, licensure, revisit, and 683 complaint survey information, for each facility. For 684 noncertified nursing homes, state survey and deficiency 685 information, including licensure, revisit, and complaint survey 686 information, shall be provided. 687 15. The results of consumer satisfaction surveys conducted 688 pursuant to s. 400.0225. 689 Section 9. Present subsections (6) and (7) of section 690 408.051, Florida Statutes, are redesignated as subsections (7) 691 and (8), respectively, and a new subsection (6) is added to that 692 section, to read: 693 408.051 Florida Electronic Health Records Exchange Act.— 694 (6) NURSING HOME DATA.—A nursing home facility as defined 695 in s. 400.021 which maintains certified electronic health record 696 technology shall make available all admission, transfer, and 697 discharge data to the agency’s Florida Health Information 698 Exchange program for the purpose of supporting public health 699 data registries and patient care coordination. The agency may 700 adopt rules to implement this subsection. 701 Section 10. Present subsections (7) through (15) of section 702 408.061, Florida Statutes, are redesignated as subsections (8) 703 through (16), respectively, a new subsection (7) is added to 704 that section, and subsections (5) and (6) of that section are 705 amended, to read: 706 408.061 Data collection; uniform systems of financial 707 reporting; information relating to physician charges; 708 confidential information; immunity.— 709 (5) Within 120 days after the end of its fiscal year, each 710 nursing home as defined in s. 408.07, excluding nursing homes 711 operated by state agencies, shall file with the agency, on forms 712 adopted by the agency and based on the uniform system of 713 financial reporting, its actual financial experience for that 714 fiscal year, including expenditures, revenues, and statistical 715 measures. Such data may be based on internal financial reports 716 that are certified to be complete and accurate by the chief 717 financial officer of the nursing home. However, a nursing home’s 718 actual financial experience shall be its audited actual 719 experience. This audited actual experience must include the 720 fiscal year-end balance sheet, income statement, statement of 721 cash flow, and statement of retained earnings and must be 722 submitted to the agency in addition to the information filed in 723 the uniform system of financial reporting. The financial 724 statements must tie to the information submitted in the uniform 725 system of financial reporting, and a crosswalk must be submitted 726 along with the financial statements. 727 (6) Within 120 days after the end of its fiscal year, the 728 home office of each nursing home as defined in s. 408.07, 729 excluding nursing homes operated by state agencies, shall file 730 with the agency, on forms adopted by the agency and based on the 731 uniform system of financial reporting, its actual financial 732 experience for that fiscal year, including expenditures, 733 revenues, and statistical measures. Such data may be based on 734 internal financial reports that are certified to be complete and 735 accurate by the chief financial officer of the nursing home. 736 However, the home office’s actual financial experience shall be 737 its audited actual experience. This audited actual experience 738 must include the fiscal year-end balance sheet, income 739 statement, statement of cash flow, and statement of retained 740 earnings and must be submitted to the agency in addition to the 741 information filed in the uniform system of financial reporting. 742 The financial statements must tie to the information submitted 743 in the uniform system of financial reporting, and a crosswalk 744 must be submitted along with the audited financial statements. 745 (7)(a) Beginning January 1, 2026, the agency shall impose 746 an administrative fine of $10,000 per violation against a 747 nursing home or home office that fails to comply with subsection 748 (5) or subsection (6), as applicable. For purposes of this 749 paragraph, the term “violation” means failing to file the 750 financial report required by subsection (5) or subsection (6), 751 as applicable, on or before the report’s due date. Failing to 752 file the report during any subsequent 10-day period occurring 753 after the due date constitutes a separate violation until the 754 report has been submitted. 755 (b) The agency shall adopt rules to implement this 756 subsection. The rules must include provisions for a nursing home 757 or home office to present factors in mitigation of the 758 imposition of the fine’s full dollar amount. The agency may 759 determine not to impose the fine’s full dollar amount upon a 760 showing that the full fine is inappropriate under the 761 circumstances. 762 Section 11. Subsection (2) of section 408.08, Florida 763 Statutes, is amended to read: 764 408.08 Inspections and audits; violations; penalties; 765 fines; enforcement.— 766 (2) Any health care facility that refuses to file a report, 767 fails to timely file a report, files a false report, or files an 768 incomplete report and upon notification fails to timely file a 769 complete report required under s. 408.061; that violates this 770 section, s. 408.061, or s. 408.20, or rule adopted thereunder; 771 or that fails to provide documents or records requested by the 772 agency under this chapter shall be punished by a fine not 773 exceeding $1,000 per day for each day in violation, to be 774 imposed and collected by the agency. Pursuant to rules adopted 775 by the agency, the agency may, upon a showing of good cause, 776 grant a one-time extension of any deadline for a health care 777 facility to timely file a report as required by this section, s. 778 408.061, or s. 408.20. A facility fined under s. 408.061(7) may 779 not be additionally fined under this subsection for the same 780 violation. 781 Section 12. Paragraph (b) of subsection (2) of section 782 409.908, Florida Statutes, is amended to read: 783 409.908 Reimbursement of Medicaid providers.—Subject to 784 specific appropriations, the agency shall reimburse Medicaid 785 providers, in accordance with state and federal law, according 786 to methodologies set forth in the rules of the agency and in 787 policy manuals and handbooks incorporated by reference therein. 788 These methodologies may include fee schedules, reimbursement 789 methods based on cost reporting, negotiated fees, competitive 790 bidding pursuant to s. 287.057, and other mechanisms the agency 791 considers efficient and effective for purchasing services or 792 goods on behalf of recipients. If a provider is reimbursed based 793 on cost reporting and submits a cost report late and that cost 794 report would have been used to set a lower reimbursement rate 795 for a rate semester, then the provider’s rate for that semester 796 shall be retroactively calculated using the new cost report, and 797 full payment at the recalculated rate shall be effected 798 retroactively. Medicare-granted extensions for filing cost 799 reports, if applicable, shall also apply to Medicaid cost 800 reports. Payment for Medicaid compensable services made on 801 behalf of Medicaid-eligible persons is subject to the 802 availability of moneys and any limitations or directions 803 provided for in the General Appropriations Act or chapter 216. 804 Further, nothing in this section shall be construed to prevent 805 or limit the agency from adjusting fees, reimbursement rates, 806 lengths of stay, number of visits, or number of services, or 807 making any other adjustments necessary to comply with the 808 availability of moneys and any limitations or directions 809 provided for in the General Appropriations Act, provided the 810 adjustment is consistent with legislative intent. 811 (2) 812 (b) Subject to any limitations or directions in the General 813 Appropriations Act, the agency shall establish and implement a 814 state Title XIX Long-Term Care Reimbursement Plan for nursing 815 home care in order to provide care and services in conformance 816 with the applicable state and federal laws, rules, regulations, 817 and quality and safety standards and to ensure that individuals 818 eligible for medical assistance have reasonable geographic 819 access to such care. 820 1. The agency shall amend the long-term care reimbursement 821 plan and cost reporting system to create direct care and 822 indirect care subcomponents of the patient care component of the 823 per diem rate. These two subcomponents together shall equal the 824 patient care component of the per diem rate. Separate prices 825 shall be calculated for each patient care subcomponent, 826 initially based on the September 2016 rate setting cost reports 827 and subsequently based on the most recently audited cost report 828 used during a rebasing year. The direct care subcomponent of the 829 per diem rate for any providers still being reimbursed on a cost 830 basis shall be limited by the cost-based class ceiling, and the 831 indirect care subcomponent may be limited by the lower of the 832 cost-based class ceiling, the target rate class ceiling, or the 833 individual provider target. The ceilings and targets apply only 834 to providers being reimbursed on a cost-based system. Effective 835 October 1, 2018, a prospective payment methodology shall be 836 implemented for rate setting purposes with the following 837 parameters: 838 a. Peer Groups, including: 839 (I) North-SMMC Regions 1-9, less Palm Beach and Okeechobee 840 Counties; and 841 (II) South-SMMC Regions 10-11, plus Palm Beach and 842 Okeechobee Counties. 843 b. Percentage of Median Costs based on the cost reports 844 used for September 2016 rate setting: 845 (I) Direct Care Costs........................100 percent. 846 (II) Indirect Care Costs......................92 percent. 847 (III) Operating Costs.........................86 percent. 848 c. Floors: 849 (I) Direct Care Component.....................95 percent. 850 (II) Indirect Care Component................92.5 percent. 851 (III) Operating Component...........................None. 852 d. Pass-through Payments..................Real Estate and 853 ...............................................Personal Property 854 ...................................Taxes and Property Insurance. 855 e. Quality Incentive Program Payment 856 Pool.....................................10 percent of September 857 .......................................2016 non-property related 858 ................................payments of included facilities. 859 f. Quality Score Threshold to Qualify Quality for Quality 860 Incentive Payment...........................................20th 861 ..............................percentile of included facilities. 862 g. Fair Rental Value System Payment Parameters: 863 (I) Building Value per Square Foot based on 2018 RS Means. 864 (II) Land Valuation...10 percent of Gross Building value. 865 (III) Facility Square Footage......Actual Square Footage. 866 (IV) Movable Equipment Allowance..........$8,000 per bed. 867 (V) Obsolescence Factor......................1.5 percent. 868 (VI) Fair Rental Rate of Return................8 percent. 869 (VII) Minimum Occupancy.......................90 percent. 870 (VIII) Maximum Facility Age.....................40 years. 871 (IX) Minimum Square Footage per Bed..................350. 872 (X) Maximum Square Footage for Bed...................500. 873 (XI) Minimum Cost of a renovation/replacements$500 per bed. 874 h. Ventilator Supplemental payment of $200 per Medicaid day 875 of 40,000 ventilator Medicaid days per fiscal year. 876 2. The agency shall revise its methodology for calculating 877 Quality Incentive Program payments to include the results of 878 consumer satisfaction surveys conducted pursuant to s. 400.0225 879 as a measure of nursing home quality. The agency shall so revise 880 the methodology after the surveys have been in effect for an 881 amount of time the agency deems sufficient for statistical and 882 scientific validity as a meaningful quality measure that may be 883 incorporated into the methodology. 884 3. The direct care subcomponent shall include salaries and 885 benefits of direct care staff providing nursing services 886 including registered nurses, licensed practical nurses, and 887 certified nursing assistants who deliver care directly to 888 residents in the nursing home facility, allowable therapy costs, 889 and dietary costs. This excludes nursing administration, staff 890 development, the staffing coordinator, and the administrative 891 portion of the minimum data set and care plan coordinators. The 892 direct care subcomponent also includes medically necessary 893 dental care, vision care, hearing care, and podiatric care. 894 4.3. All other patient care costs shall be included in the 895 indirect care cost subcomponent of the patient care per diem 896 rate, including complex medical equipment, medical supplies, and 897 other allowable ancillary costs. Costs may not be allocated 898 directly or indirectly to the direct care subcomponent from a 899 home office or management company. 900 5.4. On July 1 of each year, the agency shall report to the 901 Legislature direct and indirect care costs, including average 902 direct and indirect care costs per resident per facility and 903 direct care and indirect care salaries and benefits per category 904 of staff member per facility. 905 6.5. Every fourth year, the agency shall rebase nursing 906 home prospective payment rates to reflect changes in cost based 907 on the most recently audited cost report for each participating 908 provider. 909 7.6. A direct care supplemental payment may be made to 910 providers whose direct care hours per patient day are above the 911 80th percentile and who provide Medicaid services to a larger 912 percentage of Medicaid patients than the state average. 913 8.7. Pediatric, Florida Department of Veterans Affairs, and 914 government-owned facilities are exempt from the pricing model 915 established in this subsection and shall remain on a cost-based 916 prospective payment system. Effective October 1, 2018, the 917 agency shall set rates for all facilities remaining on a cost 918 based prospective payment system using each facility’s most 919 recently audited cost report, eliminating retroactive 920 settlements. 921 9. By October 1, 2025, and each year thereafter, the agency 922 shall submit to the Governor, the President of the Senate, and 923 the Speaker of the House of Representatives a report on each 924 Quality Incentive Program payment made pursuant to sub 925 subparagraph 1.e. The report must, at a minimum, include all of 926 the following information: 927 a. The name of each facility that received a Quality 928 Incentive Program payment and the dollar amount of such payment 929 each facility received. 930 b. The total number of quality incentive metric points 931 awarded by the agency to each facility and the number of points 932 awarded by the agency for each individual quality metric 933 measured. 934 c. An examination of any trends in the improvement of the 935 quality of care provided to nursing home residents which may be 936 attributable to incentive payments received under the Quality 937 Incentive Program. The agency shall include examination of 938 trends both for the program as a whole as well as for each 939 individual quality metric used by the agency to award program 940 payments. 941 942 It is the intent of the Legislature that the reimbursement plan 943 achieve the goal of providing access to health care for nursing 944 home residents who require large amounts of care while 945 encouraging diversion services as an alternative to nursing home 946 care for residents who can be served within the community. The 947 agency shall base the establishment of any maximum rate of 948 payment, whether overall or component, on the available moneys 949 as provided for in the General Appropriations Act. The agency 950 may base the maximum rate of payment on the results of 951 scientifically valid analysis and conclusions derived from 952 objective statistical data pertinent to the particular maximum 953 rate of payment. The agency shall base the rates of payments in 954 accordance with the minimum wage requirements as provided in the 955 General Appropriations Act. 956 Section 13. Subsection (1), paragraph (d) of subsection 957 (2), and paragraph (a) of subsection (5) of section 409.91256, 958 Florida Statutes, are amended to read: 959 409.91256 Training, Education, and Clinicals in Health 960 (TEACH) Funding Program.— 961 (1) PURPOSE AND INTENT.—The Training, Education, and 962 Clinicals in Health (TEACH) Funding Program is created to 963 provide a high-quality educational experience while supporting 964 participating federally qualified health centers, community 965 mental health centers, rural health clinics, and certified 966 community behavioral health clinics, and publicly funded 967 nonprofit organizations serving Medicaid recipients or other 968 low-income patients in areas designated as health professional 969 shortage areas and approved by the agency by offsetting 970 administrative costs and loss of revenue associated with 971 training residents and students to become licensed health care 972 practitioners. Further, it is the intent of the Legislature to 973 use the program to support the state Medicaid program and 974 underserved populations by expanding the available health care 975 workforce. 976 (2) DEFINITIONS.—As used in this section, the term: 977 (d) “Qualified facility” means a federally qualified health 978 center, a community mental health center, a rural health clinic, 979 or a certified community behavioral health clinic, or a publicly 980 funded nonprofit organization serving Medicaid recipients or 981 other low-income patients in an area designated as a health 982 professional shortage area and approved by the agency. 983 (5) REIMBURSEMENT.—Qualified facilities may be reimbursed 984 under this section only to offset the administrative costs or 985 lost revenue associated with training students, allopathic 986 residents, osteopathic residents, or dental residents who are 987 enrolled in an accredited educational or residency program based 988 in this state. 989 (a) Subject to an appropriation, the agency may reimburse a 990 qualified facility based on the number of clinical training 991 hours reported under subparagraph (3)(e)1. The allowed 992 reimbursement per student is as follows: 993 1. A medical or dental resident at a rate of $50 per hour. 994 2. A first-year medical student at a rate of $27 per hour. 995 3. A second-year medical student at a rate of $27 per hour. 996 4. A third-year medical student at a rate of $29 per hour. 997 5. A fourth-year medical student at a rate of $29 per hour. 998 6. A dental student at a rate of $22 per hour. 999 7. An advanced practice registered nursing student at a 1000 rate of $22 per hour. 1001 8. A physician assistant student at a rate of $22 per hour. 1002 9. A nursing student at a rate of $22 per hour. 1003 10. A behavioral health student at a rate of $15 per hour. 1004 11.10. A dental hygiene student at a rate of $15 per hour. 1005 Section 14. (1) To support and enhance quality outcomes in 1006 Florida’s nursing homes, the Agency for Health Care 1007 Administration shall contract with a third-party vendor to 1008 conduct a comprehensive study of nursing home quality incentive 1009 programs in other states. 1010 (a) At a minimum, the study must include a detailed 1011 analysis of quality incentive programs implemented in each of 1012 the states examined, identify components of such programs which 1013 have demonstrably improved nursing home quality outcomes, and 1014 provide recommendations to modify or enhance this state’s 1015 existing Medicaid Quality Incentive Program based on its 1016 historical performance and trends since it was first 1017 implemented. 1018 (b) The study must also include: 1019 1. An in-depth review of emerging and existing technologies 1020 applicable to nursing home care and an analysis of how their 1021 adoption in this state could improve quality of care and 1022 operational efficiency; and 1023 2. An examination of other states’ Medicaid add-on payment 1024 structures related to the provision of ventilator care, 1025 bariatric services, and behavioral health services. 1026 (2) The agency shall submit a final report on the study, 1027 including findings and actionable recommendations, to the 1028 Governor, the President of the Senate, and the Speaker of the 1029 House of Representatives by December 1, 2025. 1030 Section 15. This act shall take effect July 1, 2025.

Official text from the Florida Legislature. Formatting has been adapted for reading on Ratifi.